Cardiovascular safety of vitamin B
3
administration
Nat Med
.
2024 Sep;30(9):2446-2447.
doi: 10.1038/s41591-024-03219-9.
Epub 2024 Sep 5.
Authors
Stefan Schreiber
1
2
,
Georg H Waetzig
3
4
,
Matthias Laudes
5
6
,
Philip Rosenstiel
3
Affiliations
1
Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany. s.schreiber@mucosa.de.
2
Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein, Kiel, Germany. s.schreiber@mucosa.de.
3
Institute of Clinical Molecular Biology, Kiel University and University Hospital Schleswig-Holstein, Kiel, Germany.
4
CONARIS Research Institute AG, Kiel, Germany.
5
Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany.
6
Institute of Diabetes and Clinical Metabolism Research, Kiel University and University Hospital Schleswig-Holstein, Kiel, Germany.
PMID:
39237628
DOI:
10.1038/s41591-024-03219-9
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Cardiovascular Diseases* / chemically induced
Humans
Grants and funding
EXC 2167 (Excellence Cluster PMI)/Deutsche Forschungsgemeinschaft (German Research Foundation)